Author

Alessio Piccolantonio

Institutions: University Medical Center Groningen, University of Groningen

Observed institutions: University Medical Center Groningen, University of Groningen, University of Turin

ORCID: 0000-0002-6527-0365

Observed ORCID: 0000-0002-6527-0365

OpenAlex ID: A5090217439

The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity

2023 · Vincenzo Salemme, Giorgia Centonze, et al. · Frontiers in Oncology · 102

Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression

2022 · Giorgia Centonze, Dora Natalini, et al. · Frontiers in Oncology · 37

p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response

2023 · Vincenzo Salemme, Mauro Vedelago, et al. · Nature Communications · 17

p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells

2023 · Giorgia Centonze, Dora Natalini, et al. · Cell Death and Disease · 15

Disruption of CDK4/6–RARα–NF-κB axis attenuates senescence-associated inflammation and improves function during aging and following chemotherapy

2026 · Boshi Wang, Alessio Piccolantonio, et al. · Nature Aging · 3

Works count: 5

Citation count: 174

H-index: 4

I10-index: 4